RxDoctor Payments DataLook up a doctor →

Fisher Covin, MD

Cardiovascular Disease · Hattiesburg, MSNPI 1184665580

Payments from drug & device makers

$8,197in general payments, 2019–2025

Across 361 payments — averaging $22.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abiomed$2K
  • Boston Scientific$1K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$804
  • Shockwave Medical, Inc$768
  • Inari Medical, Inc.$494
  • Novartis$298
  • plus $3K from 40 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abiomed58$1,818
Boston Scientific54$1,379
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)74$804
Shockwave Medical, Inc16$768
Inari Medical, Inc.28$494
Novartis19$298
Endologix LLC1$235
Philips North America LLC6$198
Abbott11$195
Medtronic(3 entities)6$183
Johnson & Johnson10$160
Boehringer Ingelheim7$125
Stryker5$117
Cardiovascular Systems Inc.2$115
Biosense Webster, Inc.5$106
Amgen5$83
Scpharmaceuticals Inc.3$76
Braemar Manufacturing, LLC1$76
Cook Medical LLC4$74
W. L. Gore & Associates, Inc.3$69
Elutia, Inc.1$67
Amarin Pharma, Inc.4$63
Pfizer4$59
Celonova Biosciences, Inc.2$54
Terumo Medical Corporation3$52
Cardiva Medical, Inc.2$48
Sanofi-aventis U.S. LLC3$47
Irhythm Technologies, Inc.3$43
Baxter Healthcare1$39
Lexicon Pharmaceuticals, Inc.2$38
Cvrx, Inc.1$36
Siemens Medical Solutions USA, Inc.2$29
AstraZeneca2$27
Kestra Medical Technology Services, Inc.1$23
Actelion Pharmaceuticals US, Inc.1$20
Portola Pharmaceuticals, LLC1$20
E.r. Squibb & Sons, L.L.C.1$19
Atricure, Inc.1$18
Angiodynamics, Inc.1$17
Inspire Medical Systems, Inc.1$17
Novo Nordisk1$16
Argon Medical Devices, Inc.1$15
Akcea Therapeutics, Inc.1$15
Regeneron Healthcare Solutions, Inc.1$15
Astellas Pharma US Inc1$14
Medela LLC1$12

How this compares

$8,197 in reported general payments places this provider in the 65th percentile of 144 cardiovascular disease providers in Mississippi.

See all cardiovascular disease providers in Mississippi →

Medicare billing

Part B allowed, 2024
$332,517
Medicare patients
1,006
Services billed
4,328

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Hattiesburg

See the full list for Mississippi →

Where these figures come from

Is this you, or does something look wrong? →